Cardiovascular PET/MR imaging: Quo Vadis?

Area of Science:

• Cardiovascular Imaging
• Molecular Imaging
• Radiochemistry

Background:

• The advent of hybrid PET/MRI scanners combines the strengths of molecular imaging (PET) and high-resolution anatomical/functional imaging (MRI).
• Cardiovascular diseases require accurate diagnostic tools for early detection and mechanistic understanding.
• Current diagnostic modalities have limitations in fully characterizing complex cardiac pathologies.

Purpose of the Study:

• To explore the potential of PET/MRI in improving cardiovascular disease detection and characterization.
• To investigate the role of PET/MRI in providing mechanistic insights into cardiac disease initiation and progression.
• To assess the utility of PET/MRI in predicting myocardial recovery and treatment response.

Main Methods:

• Integration of Positron Emission Tomography (PET) with Magnetic Resonance Imaging (MRI) scanners.
• Utilization of diverse PET radiotracers for molecular imaging.
• Application of multi-parametric imaging capabilities of MRI.

Main Results:

• PET/MRI shows clinical potential for identifying and characterizing infiltrative cardiac diseases like sarcoidosis, myocarditis, and cardiac tumors.
• PET/MRI holds promise for identifying vulnerable atherosclerotic plaques, pending further clinical validation.
• The combination of molecular and multi-parametric imaging may yield predictive parameters for treatment response in cardiomyopathies.

Conclusions:

• PET/MRI is emerging as a valuable clinical tool for specific cardiovascular conditions.
• Further clinical translation and validation are necessary for applications like atherosclerotic plaque imaging.
• PET/MRI is poised to significantly advance cardiovascular disease management and research.